CBM Lifemotion announces the European launch of the Lifemotion System following CE mark approval. The first European clinical cases were successfully completed at University Hospital of Hannover in Germany and University Hospital Virgen de la Arrixaca in Murcia, Spain, marking the system's first use outside China, where it has already supported thousands of critically ill patients.
In a landmark case for lung transplantation, University Hospital of Hannover successfully treated two patients using the Lifemotion System, representing the first clinical applications outside the People's Republic of China.
Meanwhile, in Spain, the Lifemotion System demonstrated its full transport capabilities during an inter-hospital patient retrieval, operating entirely on battery power — including motor, pump, and oxygenator. This case highlighted the system’s exceptional mobility and reliability in critical-care transport, reinforcing its role as a game-changing solution in extracorporeal life support.
The Lifemotion ECMO system is CE approved for extended 14-day use, including the approval of its individual components as standalone devices, setting a new benchmark for sustained critical care support.
At both centers, clinicians praised the system’s innovative pump design, low pressure drop performance of the oxygenator, and intuitive, easy-to-use interface.
"The Lifemotion System offers a new level of flexibility and reliability in ECLS. Its compact design and battery-powered operation proved especially valuable during patient transport — with great potential for ICU, retrieval, and emergency use," said Michael van Driel, Vice President of International Business Development at CBM Lifemotion S.r.l.
To showcase the initial clinical experiences with the system, CBM Lifemotion hosted a highly successful Lunch Symposium at EuroELSO 2025 in Milan on Thursday, April 24. The event brought together internationally renowned clinical experts and leaders in extracorporeal support.
The panel, chaired by Prof. Heidi Dalton (ECMO specialist and pediatric intensivist, Scottsdale, USA), Prof. Roberto Lorusso (Professor of Cardiac Surgery and Extracorporeal Life Support, and ECLS researcher, Maastricht, The Netherlands), and Prof. Gregory J. Schears (ECMO specialist and anesthesiologist, Rochester, USA), explored the first European applications of the Lifemotion System. They also discussed its expanding clinical potential across Europe and worldwide, highlighting its role in advancing the future of extracorporeal life support.
The Lunch Symposium featured an engaging roundtable discussion with key contributions from:
In a landmark case for lung transplantation, University Hospital of Hannover successfully treated two patients using the Lifemotion System, representing the first clinical applications outside the People's Republic of China.
Meanwhile, in Spain, the Lifemotion System demonstrated its full transport capabilities during an inter-hospital patient retrieval, operating entirely on battery power — including motor, pump, and oxygenator. This case highlighted the system’s exceptional mobility and reliability in critical-care transport, reinforcing its role as a game-changing solution in extracorporeal life support.
The Lifemotion ECMO system is CE approved for extended 14-day use, including the approval of its individual components as standalone devices, setting a new benchmark for sustained critical care support.
At both centers, clinicians praised the system’s innovative pump design, low pressure drop performance of the oxygenator, and intuitive, easy-to-use interface.
"The Lifemotion System offers a new level of flexibility and reliability in ECLS. Its compact design and battery-powered operation proved especially valuable during patient transport — with great potential for ICU, retrieval, and emergency use," said Michael van Driel, Vice President of International Business Development at CBM Lifemotion S.r.l.
To showcase the initial clinical experiences with the system, CBM Lifemotion hosted a highly successful Lunch Symposium at EuroELSO 2025 in Milan on Thursday, April 24. The event brought together internationally renowned clinical experts and leaders in extracorporeal support.
The panel, chaired by Prof. Heidi Dalton (ECMO specialist and pediatric intensivist, Scottsdale, USA), Prof. Roberto Lorusso (Professor of Cardiac Surgery and Extracorporeal Life Support, and ECLS researcher, Maastricht, The Netherlands), and Prof. Gregory J. Schears (ECMO specialist and anesthesiologist, Rochester, USA), explored the first European applications of the Lifemotion System. They also discussed its expanding clinical potential across Europe and worldwide, highlighting its role in advancing the future of extracorporeal life support.
The Lunch Symposium featured an engaging roundtable discussion with key contributions from:
- PD Dr. Bettina Wiegmann (University Hospital of Hannover Medical School,Germany) — presenting the First Clinical Experience with the CBM Lifemotion System in Europe
- Prof. Simon Sin (Queen Mary Hospital, Hong Kong) — speaking on The Importance of Training and Education in ECLS/ECMO
- Dr. Hua Zhong Zhang (Nanjing Medical University, China) — sharing insights into Practical Experience of ECPR in China
These expert perspectives reinforced the strong clinical value, flexibility, and future potential of the Lifemotion System across diverse ECMO applications and healthcare settings. The enthusiastic reception of the Lifemotion System at EuroELSO confirmed its strong relevance to real-world clinical needs and its potential to transform ECMO care globally.
